Menu
Search
|

Menu

Close
X

Surmodics Inc SRDX.OQ (NASDAQ Stock Exchange Global Select Market)

55.25 USD
-1.58 (-2.78%)
As of Nov 20
chart
Previous Close 56.83
Open 56.49
Volume 34,338
3m Avg Volume 35,077
Today’s High 57.37
Today’s Low 54.84
52 Week High 82.35
52 Week Low 25.00
Shares Outstanding (mil) 13.11
Market Capitalization (mil) 417.55
Forward P/E 68.97
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.75 Mean rating from 4 analysts

KEY STATS

Revenue (mm, USD)
FY18
81
FY17
73
FY16
71
FY15
62
EPS (USD)
FY18
-0.224
FY17
0.292
FY16
0.759
FY15
0.903
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
68.97
33.59
Price to Sales (TTM)
vs sector
5.86
5.69
Price to Book (MRQ)
vs sector
3.82
5.11
Price to Cash Flow (TTM)
vs sector
36.80
23.52
Total Debt to Equity (MRQ)
vs sector
0.00
15.71
LT Debt to Equity (MRQ)
vs sector
0.00
11.53
Return on Investment (TTM)
vs sector
5.07
15.05
Return on Equity (TTM)
vs sector
5.82
16.62

EXECUTIVE LEADERSHIP

Susan Knight
Independent Chairman of the Board, Since 2015
Salary: --
Bonus: --
Gary Maharaj
President, Chief Executive Officer, Director, Since 2010
Salary: $525,675.00
Bonus: --
Timothy Arens
Interim Vice President, Finance, and Chief Financial Officer, and Principal Financial Officer, Vice President - Corporate Development and Strategy, Since 2018
Salary: $226,513.00
Bonus: $40,000.00
Thomas Greaney
Chief Operating Officer - Medical Devices, Since 2017
Salary: $289,108.00
Bonus: --
Teri Sides
Senior Vice President, Chief Marketing Officer, Since 2018
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

9924 W 74th St
EDEN PRAIRIE   MN   55344-3523

Phone: +1952.5007000

Surmodics, Inc. is a provider of medical device and in vitro diagnostic technologies to the healthcare industry. The Company operates through two segments: Medical Device and In Vitro Diagnostics. The Company's Medical Device segment consists of surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices; international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device. The Company's In Vitro Diagnostics segment manufactures or sells components for in vitro diagnostic immunoassay and molecular tests. The In Vitro Diagnostics segment manufactures and sells surface coatings to the diagnostic, biomedical research and life science markets. In Vitro Diagnostics segment offers protein stabilization reagents, substrates, antigens and surface coatings.

SPONSORED STORIES